Sino Medical Sciences Stock Revenue
| 688108 Stock | 10.23 0.02 0.20% |
Sino Medical Sciences fundamentals help investors to digest information that contributes to Sino Medical's financial success or failures. It also enables traders to predict the movement of Sino Stock. The fundamental analysis module provides a way to measure Sino Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sino Medical stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 308.9 M | 246.2 M |
Sino | Revenue |
Sino Medical Sciences Company Revenue Analysis
Sino Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Sino Medical Revenue | 343.26 M |
Most of Sino Medical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sino Medical Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Sino
Projected quarterly revenue analysis of Sino Medical Sciences provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Sino Medical match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Sino Medical's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Sino Total Revenue
Total Revenue |
|
Based on the latest financial disclosure, Sino Medical Sciences reported 343.26 M of revenue. This is 95.5% lower than that of the Health Care Equipment & Supplies sector and 86.54% lower than that of the Health Care industry. The revenue for all China stocks is 96.36% higher than that of the company.
Sino Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sino Medical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sino Medical could also be used in its relative valuation, which is a method of valuing Sino Medical by comparing valuation metrics of similar companies.Sino Medical is currently under evaluation in revenue category among its peers.
Sino Fundamentals
| Return On Equity | 0.0017 | ||||
| Return On Asset | -0.0247 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 4.15 B | ||||
| Shares Outstanding | 413.46 M | ||||
| Shares Owned By Insiders | 33.74 % | ||||
| Shares Owned By Institutions | 9.61 % | ||||
| Price To Book | 4.94 X | ||||
| Price To Sales | 9.24 X | ||||
| Revenue | 343.26 M | ||||
| Gross Profit | 458.74 M | ||||
| EBITDA | 31.95 M | ||||
| Net Income | (49.32 M) | ||||
| Total Debt | 69.27 M | ||||
| Book Value Per Share | 2.07 X | ||||
| Cash Flow From Operations | 56.84 M | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 14.0 | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 4.24 B | ||||
| Total Asset | 1.19 B | ||||
| Retained Earnings | (234.73 M) | ||||
| Working Capital | 192.9 M | ||||
| Net Asset | 1.19 B |
About Sino Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sino Medical Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sino Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sino Medical Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sino Stock
Sino Medical financial ratios help investors to determine whether Sino Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sino with respect to the benefits of owning Sino Medical security.